Welcome to University of Mumbai, Department of Biophysics


Bioinformatics Database on
"Radiosensitisers and Radioprotectors"

Alphabetical Search   >  L   >  Liv. 52                                                                                                                                                                  Top

Liv. 52

Go To:


General Features                  Clinical Study                  Chemical Intervention                 Pharmacological Aspects                 
Radiobiological Aspects                  Biological Models                  Biological Target                  Toxicity                 


GENERAL FEATURES

Name: Liv. 52
Trade name: Liv. 52® (Himalayan Drug Company)[1],[2]
Composition: Capparis spinosa,
Cichorium intybus,
Solanum nigrum,
Terminalia arjuna,
Cassia occidentalis,
Achillea millefolium,
Tamarix gallica,
Mandur Bhasma[3]
Chemical Nature:
Actions
& Indications:
Pharmcological Action-
hepatoprotective in rats[4],[5]
Therapeutic indications-
Protects liver from various hepatotoxins, promotes appetite[3],[2]
Preclinical study-
Liv.52 tablets and drops are found to be highly effective in the treatment of short- and long-duration anorexia of various etiologies in children[6]
Notes:
REFERENCES
1. Controversies in the Clinical Evaluation of Antifertility Planat by Chaudhury RR ; In :Clinical Pharmacology & Therapeutics: Proceedings of First World Conference on Clinical Pharmacology & Therapeutics, edited by Turner P, Macmillan, 1980, Page no. 479.
https://books.google.com.sg/books?id=vCOwCwAAQBAJ&pg=PA479
2. 17 : Complementary Medicine; In : Hepatitis: Causes, Treatments and Resources by Moore EA, Mcfarland & Company, 2006, Page no. 295.
https://books.google.com.sg/books?id=2lSDBAAAQBAJ&pg=PA295
3. 10: Ayurveda Siddha Unani Companies and their Products; In :Handbook On Herbal Products (Medicines, Cosmetics, Toiletries, Perfumes) Vol. II by NIIR Board of Technologies, Page no. 571.
https://books.google.com.sg/books?id=izWJDAAAQBAJ&pg=PT368
4. Sapakal PD et al, Comparative hepatoprotective activity of Liv-52 and livomyn against carbon tetrachloride-induced hepatic injury in rats. International Journal of Green Pharmacy. 2008;2(2):79-82.
http://www.greenpharmacy.info/index.php/ijgp/article/view/33
5. Pandey S et al, Hepato protective effect of Liv52 against CCl4 induced lipid peroxidation in liver of rats. Indian J Exp Biol. 1994 ;32(9):674-5.
http://www.ncbi.nlm.nih.gov/pubmed/7814050
6. Bhattacharya S, Kolhapure SA, Evaluation of efficacy and safety of Liv.52 tablets & Liv.52 drops in anorexia in children. Capsule 2004; XV(8): 1-2.
http://himalayacentroamericana.com/himalaya_researchpapers/pdf_files/liv261.pdf